Clinical Trial Update: A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating belatacept in kidney transplant recipients on stable cyclosporine or tacrolimus regimens, with or without corticosteroids; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Nulojix (belatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Renal Transplant | Phase 2 | Status: COMPLETED | Results posted: 2017-01-05